File:PCP4 Western blot with knock-down and control H295R adrenocortical cells.jpg
Size of this preview: 555 × 600 pixels. Other resolutions: 222 × 240 pixels | 444 × 480 pixels | 710 × 768 pixels | 1,248 × 1,349 pixels.
Original file (1,248 × 1,349 pixels, file size: 81 KB, MIME type: image/jpeg)
 | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
Summary
| Description |
English: Western blotting of PCP4 (down, 7.6kDa) and beta-actin (control marker, up, 42kDa) in two samples of H295R human adrenocortical carcinoma cells. Sample number 1 was submitted to PCP4 transient knockdown using a MISSION® esiRNA (SIGMA-ALDRICH), while sample number 2 was transfected with a universal negative-control siRNA. H295R cells were transfected using a Nucleofector-4D (LONZA). All methods were carried out as published by Felizola SJA et al 2014 Journal of Molecular Endocrinology 52(2):159-67. doi: 10.1530/JME-13-0248.[1] |
| Date | |
| Source | Western blotting of PCP4 and beta-actin (control marker) in two samples of H295R human adrenal cortex carcinoma cell line according to published methods. |
| Author | Herizora |
- Other information
English: Western blotting of PCP4 (down, 7.6kDa) and beta-actin (control marker, up, 42kDa) in two samples of H295R human adrenal carcinoma cells. Sample number 1 was submitted to PCP4 transient knockdown using a MISSION® esiRNA (SIGMA-ALDRICH), while sample number 2 was transfected with a universal negative-control siRNA. H295R cells were transfected using a Nucleofector-4D (LONZA). PCP4 antibody (rabbit anti-human, polyclonal) was purchased from SIGMA-ALDRICH and used at 1:400 concentration. All methods were carried out as published by Felizola SJA et al 2014 Journal of Molecular Endocrinology 52(2):159-67. doi: 10.1530/JME-13-0248.[1]
Licensing
I, the copyright holder of this work, hereby publish it under the following licenses:
|
Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled GNU Free Documentation License. |
This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
You may select the license of your choice.
- ↑ a b Saulo J.A. Felizola, Yasuhiro Nakamura, Yoshikiyo Ono, Kanako Kitamura, Kumi Kikuchi, Yoshiaki Onodera, Kazue Ise, Kei Takase, Akira Sugawara, Namita Hattangady, William E. Rainey, Fumitoshi Satoh, Hironobu Sasano. (Feb 2014). "PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues.". Journal of Molecular Endocrinology 52 (2): 159-167. DOI:10.1530/JME-13-0248. PMID 24403568.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 05:33, 17 October 2014 | | 1,248 × 1,349 (81 KB) | Herizora | {{subst:Upload marker added by en.wp UW}} {{Information |Description = {{en|Western blotting of PCP4 (down, 7.6kDa) and beta-actin (control marker, up, 42kDa) in two samples of H295R human adrenocortical carcinoma cells. Sample number 1 was submitt... |
File usage
No pages on the English Wikipedia use this file (pages on other projects are not listed).
